drugset / Trial / NCT07362927
Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
Phase 0
Recruiting
32 enrolled
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Innostellar Biotherapeutics · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
The goal of this study is to evaluate the safety and efficacy of LX111 treatment of DME. This study will enroll participants aged ≥ 18 vears old to receive a single unilateral intravitreal (lVT) injection of LX111 to evaluate its safety and efficacy.
Timeline
- Start
- 2026-03
- Primary completion
- 2027-09
- Completion
- 2031-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX111 | Gene therapy (AAV / viral vector) | — | Intravitreal |